Press release - Spital Lachen and the Hirslanden Group extend their cooperation
01.12.2021 | PDF | 340.69 KB
The Hirslanden Group has taken a stake of about 10% in Spital Lachen AG and will have a seat on the Management Board. The cooperation will give a further boost to the competitiveness of Spital Lachen and the quality of the medical services it offers.
Spital Lachen and Hirslanden’s Klinik Im Park have been working in partnership with each other in the field of cardiology since January 2021. The range of cardiological services offered by each hospital complements the range of the other hospital in a perfect fit. The cardiology provided by Spital Lachen with its large outpatient clinic and the skills and experience of the Klinik Im Park extending across the entire spectrum of cardiology and heart surgery in what is known as a “tertiary centre” combine to offer the population of the canton of Schwyz a high level of integrated service and care. Using the experience gained in this collaboration, Spital Lachen and the Hirslanden Group are now planning to expand their cooperation to other fields of medicine.
Nicole Fritsche, a member of the Spital Lachen AG Board of Management and also a member of the Höfe District Council emphasised that “As a result of the partnership and the minority share taken by Hirslanden, our competitiveness is further strengthened and the primary inpatient and outpatient primary medical care of the people of the districts of March and Höfe is placed on a firm footing for very many years to come.” Access to doctors with highly specialised experience in selected areas of medicine is also improved as well as the range of specialist medical services, for example by the exchange of professional staff. And at the same time Spital Lachen remains an independent institution. “Accompanied by a strong partner in the form of Hirslanden, new opportunities open up for us without the loss of our identity” stated Franziska Berger, CEO of Spital Lachen. “Last but certainly not least, the increase in our equity capital ensures we have the means to finance our forward-looking FUTURA construction project.” The aim of this project is the modernisation of Spital Lachen’s infrastructure.
The cooperation with Spital Lachen is fully in keeping with the declared strategic objective of the Hirslanden Group of joining with selected partners to offer comprehensive medical treatment along the entire chain of medical care. Dr. Stephan Pahls, the Hirslanden Group’s Chief Operating Officer, East and recently appointed to the Management Board of Spital Lachen AG explains: “We are delighted with the extension of our cooperation with Spital Lachen which follows the agreement we announced on cardiology a year ago. This new cooperation will promote efficient and high-quality medical care integrated into the local community and therefore offering a real gain for the people of Schwyz.”
Das Spital Lachen ist eine Aktiengesellschaft der Bezirke March und Höfe und stellt seit über 100 Jahren die medizinische Versorgung für den Bezirk March und seit 1962 für den Bezirk Höfe im Kanton Schwyz sicher. Es gilt als patientenorientiertes und regional verankertes Gesundheitszentrum mit einer qualitativ hochstehenden und umfassenden Leistungspalette. Im Fokus stehen ambulante und stationäre Behandlungen von akut Erkrankten und Verunfallten. Zur Sicherheit der Bevölkerung tragen ein professioneller Rettungsdienst und die rund um die Uhr besetzte Notfallstation bei. In Zusammenarbeit mit den niedergelassenen Ärztinnen und Ärzten sowie den übrigen im Gesundheitswesen tätigen Institutionen in der Region erfolgt eine integrierte Gesundheitsversorgung. Eine enge Zusammenarbeit mit Kooperationspartnern im Kanton Schwyz und in den Nachbarkantonen erweitert das Leistungsspektrum.
Spital Lachen is a joint-stock company of the districts of March and Höfe and has been providing medical care for the district of March for over 100 years and for the district of Höfe in the canton of Schwyz since 1962. It is considered a patient-oriented and regionally anchored health centre with a high-quality and comprehensive range of services. The focus lies on outpatient and inpatient care for the acutely ill and casualties. A professional emergency service and a round-the-clock emergency department contribute to the safety of the population. Integrated healthcare is provided in cooperation with local doctors and other institutions working within healthcare in the region. Close cooperation with partners in the canton of Schwyz and neighbouring cantons extends the range of services.
The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgical units, 17 radiology institutes and 5 radiotherapy institutes. Together with public and private cooperation partners, Hirslanden focuses on the continuum of care and the promoting of high-quality, responsible, personalised and efficiently integrated healthcare.
The Group has 2,314 partner doctors and 10,711 employees, 479 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2020/21 financial year the Group generated a turnover of CHF 1,796 million (including CHF 12.6 million cantonal COVID-19 compensation payments). As at 31 March 2021, the Group had treated 107,401 patients for a total of 461,004 inpatient days. In insurance terms, the patient mix consists of 51 % basic, 28.8 % semi-private, and 20.2 % private insured patients.
Hirslanden is synonymous with first-class medical care provided by highly qualified medical specialists with many years of experience. As a system provider, the Group stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.